Long-Term Outcomes, Morbidity and Quality of Life in Node-Negative Early-Stage Vulvar Cancer: Sentinel Node Biopsy versus Inguinofemoral Lymphadenectomy
Geburtshilfe und Frauenheilkunde · 01.08.2026 · 86 (08) · 746-753
DOI: 10.1055/a-2893-8951 ↗Kurz gefasst
Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 01.08.2026. Verfasst von Sarah Tanskanen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and GynecologyCologne-Kalk HospitalCologneGermany. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
To compare recurrence, survival, morbidity, and quality of life in early-stage vulvar cancer patients with tumour-free lymph nodes undergoing sentinel lymph node biopsy (SNB) versus inguinofemoral lymphadenectomy (IFL). Study Design A total of 74 vulvar cancer patients (SNB: n = 58; IFL: n = 16) with a tumour size of < 4 cm and tumour-free lymph nodes were included. Endpoints were overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS). DFS was further divided into local, inguinal, or distant recurrence. Additionally, morbidity and quality of life were analysed.
Results
No significant differences in survival outcomes were observed after a median follow-up of 58.0 months for OS, 59.1 months for DSS, and 40.0 months for DFS. Inguinal recurrences occurred in two patients in the SNB group (3.77%) and in none of the patients in the IFL group (0%). However, DFS related to isolated inguinal recurrence did not differ significantly between the groups (96.2% vs. 100%, p = 0.374). Complications were less frequent following SNB, with a significant difference observed only for lymphocele formation (13.8% vs. 50%; p = 0.02). Quality of life scores did not differ significantly between the groups.
Conclusion
This study confirms SNB as an oncologically safe procedure. Although inguinal recurrences were slightly more frequent after SNB, there was no significant difference in DSS, DFS, or OS. Lymphocele was significantly more common after IFL, without impacting self-reported quality of life.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and GynecologyCologne-Kalk HospitalCologneGermany.
- Department of Obstetrics and GynaecologyFlorence Nightingale HospitalDüsseldorfGermany.
- Department of Obstetrics and GynaecologyFaculty of Medicine and University Hospital Cologne, University of CologneCologneGermany.
- Department of Obstetrics and GynecologyUniversity Hospital of Essen, University of Duisburg-Essen, Faculty of MedicineEssenGermany.
- Institute of Medical Statistics and Computational BiologyFaculty of Medicine and University Hospital Cologne, University of CologneCologneGermany.
ORCID-Profile: Dirk M Forner
Zitieren
APA
Tanskanen, S., Lampe, B., Mallmann, P., Thangarajah, F., Heiden, P., & Forner, D. M. (2026). Long-Term Outcomes, Morbidity and Quality of Life in Node-Negative Early-Stage Vulvar Cancer: Sentinel Node Biopsy versus Inguinofemoral Lymphadenectomy. Geburtshilfe und Frauenheilkunde, 86(08), 746-753. https://doi.org/10.1055/a-2893-8951
Vancouver
Tanskanen S, Lampe B, Mallmann P, Thangarajah F, Heiden P, Forner DM. Long-Term Outcomes, Morbidity and Quality of Life in Node-Negative Early-Stage Vulvar Cancer: Sentinel Node Biopsy versus Inguinofemoral Lymphadenectomy. Geburtshilfe und Frauenheilkunde. 2026;86(08):746-753. doi:10.1055/a-2893-8951
BibTeX
@article{Tanskanen2026,
author = {Tanskanen, Sarah and Lampe, Björn and Mallmann, Peter and Thangarajah, Fabinshy and Heiden, Pierce and Forner, Dirk M},
title = {Long-Term Outcomes, Morbidity and Quality of Life in Node-Negative Early-Stage Vulvar Cancer: Sentinel Node Biopsy versus Inguinofemoral Lymphadenectomy},
journal = {Geburtshilfe und Frauenheilkunde},
year = {2026},
volume = {86},
number = {08},
pages = {746--753},
doi = {10.1055/a-2893-8951}
}
EUVIMED